首页 > 市场调查报告书 > 製药

以基因为基之药物开发

市场调查报告书

商品编码

1547487

全球全基因组扩增市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Whole Genome Amplification Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球全基因组扩增市场需求预计将从 2023 年的 341 万美元达到近 707 万美元的市场规模，2024-2032 年研究期间复合年增长率为 8.44%。

全基因组扩增（WGA）是整个基因组被扩增的过程。过程开始时保留的奈克 DNA 量被转换为微克扩增产物。它的工作原理是聚合酶炼式反应，透过酶复製基因组样本中的 DNA。 WGA 被认为是一种重要的工具，因为它可以藉助少量的基因组 DNA 来增加有限数量的 DNA 样本。它对于研究生物体的基因非常有用，这是用保存的有限样本完成的。该过程广泛用于许多应用。

市场动态

全基因组扩增在各领域的应用不断增加是推动WGA市场的关键因素。由于 WGA 越来越多地用于诊断遗传性疾病和胚胎疾病、基因分型、法医和旧 DNA 样本分析，WGA 预计将出现良好的增长。此外，人们对 WGA 认识的提高、对临床试验和分子生物学应用的大量投资将有助于 WGA 市场的成长。然而，WGA 的结果可能会因用于定序、扩增和提取 DNA 的两种不同技术（即 PCR WGA 和 REPLI-g）而有所不同，这一事实可能会阻碍市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球全基因组扩增市场的每个细分市场进行了包容性评估。全基因组扩增产业的成长和趋势为这项研究提供了整体方法。

市场区隔

全基因组扩增市场报告的这一部分提供了有关国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按类型

单细胞 WGA 试剂盒
完整的 WGA 套件
WGA 再次扩增套件
WGA 和晶片 DNA 试剂盒
其他的

按申请

药物发现与开发
疾病诊断
农业与兽医
研究
法证学
其他的

按最终用户

製药与生物技术公司
合约研究
医院和诊所
研究与学术机构
组织机构
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲全基因组扩增市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。全基因组扩增市场的主要参与者包括 Qiagen NV、LGC Group、Sigma-Aldrich、GE Healthcare。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：全基因组扩增公司的竞争格局

全基因组扩增市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Qiagen NV

公司概况
公司收入
产品
最新动态

LGC Group

公司概况
公司收入
产品
最新动态

Sigma-Aldrich

公司概况
公司收入
产品
最新动态

GE Healthcare

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11215177

The global demand for Whole Genome Amplification Market is presumed to reach the market size of nearly USD 7.07 Million by 2032 from USD 3.41 Million in 2023 with a CAGR of 8.44% under the study period 2024-2032.

Whole-genome amplification (WGA) is a process where an entire genome gets amplified. The quantity of DNA which remains in nanograms at the beginning of the process gets converted into micrograms of amplified products. It works on the principles of polymerase chain reaction, which enzymatically replicates the DNA from the genome specimen. WGA is considered an important tool as it increases the limited number of DNA specimens with the help of a small quantity of genomic DNA. It is very useful for studying the gene of an organism, which is done with the conserved limited specimen. This procedure is widely used in a number of applications.

MARKET DYNAMICS

The increasing application of whole genome amplification in various fields is a key factor driving the WGA market. The WGA is expected to witness favorable growth owing to the increasing use of WGA for diagnosing genetic disorders and embryonic disorders, genotyping, forensic, and analysis of old DNA samples. Furthermore, increasing awareness about WGA, a considerable amount of investment for clinical trials and application in molecular biology will contribute to WGA market growth. However, the fact that the result of WGA may vary with two different technologies, namely PCR WGA and REPLI-g, used for sequencing, amplifying, and extracting DNA, will probably hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Whole Genome Amplification. The growth and trends of Whole Genome Amplification industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Whole Genome Amplification market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Single Cell WGA Kit
Complete WGA Kit
WGA Reamplification Kit
WGA & Chip DNA Kit
Others

By Application

Drug Discovery & Development
Disease Diagnosis
Agriculture & Veterinary
Research
Forensics
Others

By End-User

Pharmaceutical & Biotech Companies
Contract Research
Hospitals & Clinics
Research & Academic Institutes
Organizations
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Whole Genome Amplification market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Whole Genome Amplification market include Qiagen NV, LGC Group, Sigma-Aldrich, GE Healthcare. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. WHOLE GENOME AMPLIFICATION - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL WHOLE GENOME AMPLIFICATION MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Single Cell WGA Kit Historic and Forecast Sales By Regions
5.4. Complete WGA Kit Historic and Forecast Sales By Regions
5.5. WGA Reamplification Kit Historic and Forecast Sales By Regions
5.6. WGA & Chip DNA Kit Historic and Forecast Sales By Regions
5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL WHOLE GENOME AMPLIFICATION MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Drug Discovery & Development Historic and Forecast Sales By Regions
6.4. Disease Diagnosis Historic and Forecast Sales By Regions
6.5. Agriculture & Veterinary Historic and Forecast Sales By Regions
6.6. Research Historic and Forecast Sales By Regions
6.7. Forensics Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL WHOLE GENOME AMPLIFICATION MARKET ANALYSIS BY END-USER

7.1. Overview By End-User
7.2. Historical and Forecast Data Analysis By End-User
7.3. Pharmaceutical & Biotech Companies Historic and Forecast Sales By Regions
7.4. Contract Research Historic and Forecast Sales By Regions
7.5. Hospitals & Clinics Historic and Forecast Sales By Regions
7.6. Research & Academic Institutes Historic and Forecast Sales By Regions
7.7. Organizations Historic and Forecast Sales By Regions
7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL WHOLE GENOME AMPLIFICATION MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE WHOLE GENOME AMPLIFICATION COMPANIES

9.1. Whole Genome Amplification Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF WHOLE GENOME AMPLIFICATION INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Qiagen NV
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. LGC Group
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Sigma-Aldrich
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. GE Healthcare
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments